US 11932688
Treatment for neoplastic diseases
granted A61KA61K2039/505A61P
Quick answer
US patent 11932688 (Treatment for neoplastic diseases) held by XBIOTECH INC. expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- XBIOTECH INC.
- Grant date
- Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/00, A61P11/00